Results 171 to 180 of about 39,412 (236)

Effect of Guanylate Cyclase-22-like on Ovarian Development of Orius nagaii (Hemiptera: Anthocoridae). [PDF]

Insects
Du H, Wang R, Dai X, Yin Z, Liu Y, Su L, Chen H, Zhao S, Zheng L, Dong X, Zhai Y.   +10 more
europepmc   +1 more source

Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts. [PDF]

Cells
Fioretto BS, Rosa I, Andreucci E, Mencucci R, Marini M, Romano E, Manetti M.   +6 more
europepmc   +1 more source

Structural aspects of sGC activation [PDF]

, 2019
Hammel, Michal, Horst, Benjamin G, Marletta, Michael A, Rosenberg, Daniel J   +3 more
core  

Pericyte signaling via soluble guanylate cyclase shapes the vascular niche and microenvironment of tumors. [PDF]

EMBO J
Zhu J, Yang W, Ma J, He H, Liu Z, Zhu X, He X, He J, Chen Z, Jin X, Wang X, He K, Wei W, Hu J.   +13 more
europepmc   +1 more source

The efficacy and safety of soluble guanylate cyclase modulation in patients with heart failure: a comprehensive meta-analysis of randomized controlled trials. [PDF]

Sci Rep
Arayici ME, Gunes H, Ellidokuz H, Yilmaz MB.   +3 more
europepmc   +1 more source

NMR Structure of Retinal Guanylate Cyclase Activating Protein 5 (GCAP5) with R22A Mutation That Abolishes Dimerization and Enhances Cyclase Activation. [PDF]

Biochemistry
Cudia DL, Ahoulou EO, Bej A, Janssen AN, Scholten A, Koch KW, Ames JB.   +6 more
europepmc   +1 more source

Soluble guanylate cyclase stimulators and activators: new horizons in the treatment of priapism associated with sickle cell disease. [PDF]

Front Pharmacol
Pereira DA, Silveira THR, Calmasini FB, Silva FH.   +3 more
europepmc   +1 more source

Soluble guanylate cyclase stimulators for heart failure: a network meta-analysis and subgroup analyses of reduced and preserved ejection fraction. [PDF]

Egypt Heart J
Abuelazm MT, Attia A, Abdelnabi M, Jafar U, Almaadawy O, Elzeftawy MA, Mahmoud A, Albakri K, Abdelazeem B.   +8 more
europepmc   +1 more source

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial. [PDF]

Front Pharmacol
Gui YZ, Wang W, Wu QQ, Ding QC, Qian HJ, Lu QB, Zhang YJ, Zhuang YL, Deng L, Zuo YL, Luo L, Jia JY.   +11 more
europepmc   +1 more source